China Aoxing Pharmaceutical Company, Inc. (OTC.BB: CAXG) has appointed Dr. Hui Shao as CFO. Dr. Shao will assume the position immediately. He brings an extensive background to the company, with over 14 years of experience in financial, accounting, private investment and strategic business development experience through several aspects of the global healthcare industry. Before he began his career on Wall Street, he was a Principal Scientist at Roche Pharmaceuticals.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
Dr. Shao graduated from the Stern School of Business, New York University with an MBA in Finance and Accounting. He also has a Ph.D. in Bioorganic Chemistry which he obtained from University of California, San Diego
About China Aoxing Pharmaceutical Company, Inc.
China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) is a pharmaceutical company specializing in research, development, manufacturing and distribution of a variety of narcotics and pain-management products.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
